Metoprolol Tartrate Injection — Class III drug recall D-0245-2019
Terminated recall by RemedyRepack Inc., reported 2018-11-21, distributed in NY. Failed pH Specifications: High Out-of-Specification results for pH were obtained during stability testing.
| Recall number | D-0245-2019 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | RemedyRepack Inc., Indiana, PA, United States |
| Recall initiated | 2018-10-26 |
| Classified | 2018-11-14 |
| Reported by FDA | 2018-11-21 |
| Terminated | 2019-02-05 |
| Distributed | NY |
| Quantity | 1 vials |
| Reason classes | specification failure |
| NDC | 70518-0868-00 |
| Lot numbers | A0A0253, B0369427-112717 |
| Expiration dates | 2019-02, 2019-08 |
Product
Metoprolol Tartrate Injection, USP 5mg/5mL, vials, Rx only, MFG: Claris Lifesciences Inc., North Brunswick, NJ 08902, NDC# 70518-0868-00
Reason for recall
Failed pH Specifications: High Out-of-Specification results for pH were obtained during stability testing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0245-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.